nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

26.01.2016 | Letter to the Editor

Imaging of differentiated thyroid carcinoma: ¹²⁴I-PET/MRI may not be superior to ¹²⁴I-PET/CT

verfasst von: A. Vrachimis, M. Weckesser, M. Schäfers, L. Stegger

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Binse I, Poeppel TD, Ruhlmann M, Gomez B, Umutlu L, Bockisch A, et al. Imaging with ¹²⁴I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT? Eur J Nucl Med Mol Imaging. 2015. doi:10.1007/s00259-015-3288-y.PubMed

Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52:1914–22.CrossRefPubMed

N. E. M. Association. NEMA standards publication NU 2–2012: performance measurements of positron emission tomographs. Rosslyn, VA: National Electrical Manufacturers Association; 2012.

Wiesmuller M, Quick HH, Navalpakkam B, Lell MM, Uder M, Ritt P, et al. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging. 2013;40:12–21.CrossRefPubMed

Vrachimis A, Burg MC, Wenning C, Allkemper T, Weckesser M, Schafers M, et al. F]FDG PET/CT outperforms [F]FDG PET/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016;43:212–20.

Blodgett TM, Mehta AS, Mehta AS, Laymon CM, Carney J, Townsend DW. PET/CT artifacts. Clin Imaging. 2011;35:49–63.CrossRefPubMedPubMedCentral

Bockisch A, Beyer T, Antoch G, Freudenberg LS, Kuhl H, Debatin JF, et al. Positron emission tomography/computed tomography—imaging protocols, artifacts, and pitfalls. Mol Imaging Biol. 2004;6:188–99.CrossRefPubMed

Titel: Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT
verfasst von: A. Vrachimis
M. Weckesser
M. Schäfers
L. Stegger
Publikationsdatum: 26.01.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2016
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-016-3318-4

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2016

[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies

Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET

The Pathophysiologic Basis of Nuclear Medicine, Third Edition, Abdelhamid H. Elgazzar, Ed.

Pilot prospective evaluation of 18F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer

Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer’s disease

Imaging with 124I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT?